“The Global Stem Cell Therapy Market is Expected to Grow at a Formidable Rate of Around 12% During the Forecast Period.”
FEATURED COMPANIES
- AlloSource
- Anterogen Co., Ltd.
- MEDIPOST Co., Ltd.
- NuVasive, Inc.
- Osiris Therapeutics, Inc.
- Pharmicell Co., Ltd.
Free Webex Call
Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The Global Stem Cell Therapy Market is expected to grow at a formidable rate of around 12% during the forecast period. The Global Stem Cell Therapy Market is driven by the growing popularity and awareness pertaining to the use of stem cells for the prevention and cure of certain life threatening diseases. Additionally, increase in number of stem cell banks and growing investments by the government and private organizations for the development of stem cell preservation infrastructure is further propelling the market across the globe.
The Global Stem Cell Therapy Market is segmented based on type, source of stem cells, application, end-users, company and region. Based on type, the market can be categorized into allogeneic, autologous and syngeneic. The allogenic type segment is expected to register the highest growth during forecast period attributable to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, growing number of clinical trials related to allogeneic stem cell therapies, among others. Based on end-users, the market can be bifurcated into hospitals and clinics. The hospitals segment is expected to dominate the market during the forecast years. This can be accredited to the rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately.
Regionally, the stem cell therapy market has been segmented into various regions namely Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall stem cell therapy market during the next five years on account of the increasing number of clinical trials for stem cell-based products and increasing public-private funding & research grants.
Major players operating in the Global Stem Cell Therapy Market include Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market.
Years considered for this report:
The author calculated the market size of the Global Stem Cell Therapy Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
Report Scope:
In this report, the Global Stem Cell Therapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Market, By Type:
With the given market data, the author offers customizations according to a client's specific needs.
This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
The Global Stem Cell Therapy Market is segmented based on type, source of stem cells, application, end-users, company and region. Based on type, the market can be categorized into allogeneic, autologous and syngeneic. The allogenic type segment is expected to register the highest growth during forecast period attributable to the rising commercialization of allogeneic stem cell therapy products, wider therapeutic applications of allogeneic stem cells, easy production scale-up process, growing number of clinical trials related to allogeneic stem cell therapies, among others. Based on end-users, the market can be bifurcated into hospitals and clinics. The hospitals segment is expected to dominate the market during the forecast years. This can be accredited to the rising preference for stem cell therapies offered by hospitals proves beneficial for the business growth. Hospitals have affiliations with research laboratories and academic institutes that carry out research activities for developing stem cell therapies. On introduction and approval of any novel stem therapy, hospitals implement it immediately.
Regionally, the stem cell therapy market has been segmented into various regions namely Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the overall stem cell therapy market during the next five years on account of the increasing number of clinical trials for stem cell-based products and increasing public-private funding & research grants.
Major players operating in the Global Stem Cell Therapy Market include Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., JCR Pharmaceuticals Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., AlloSource, Thermo Fisher Scientific and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market.
Years considered for this report:
- Historical Years: 2015-2018
- Base Year: 2019
- Estimated Year: 2020
- Forecast Period: 2021–2025
- To analyze and forecast the market size of the Global Stem Cell Therapy Market.
- To classify and forecast the Global Stem Cell Therapy Market based on type, source of stem cells, application, end-users, company and regional distribution.
- To identify drivers and challenges for the Global Stem Cell Therapy Market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Stem Cell Therapy Market.
- To identify and analyze the profile of leading players operating in the Global Stem Cell Therapy Market.
The author calculated the market size of the Global Stem Cell Therapy Market by using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.
Key Target Audience:
- Stem Cell therapy hospitals, clinics and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to stem cell therapy
- Market research and consulting firms
Report Scope:
In this report, the Global Stem Cell Therapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Market, By Type:
- Allogeneic
- Autologous
- Syngeneic
- Adipose Tissue
- Bone Marrow
- Neural
- Embryo/Cord Blood Derived
- iPSCs
- Others
- Musculoskeletal
- Wound & Injury
- Cardiovascular Disease (CVD)
- Surgery
- Acute Graft-Versus-Host Disease
- Drug Discovery & Development
- Others
- Hospitals
- Clinics
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- South America
- Brazil
- Argentina
- Colombia
- Company Profiles: Detailed analysis of the major companies present in the Global Stem Cell Therapy Market.
With the given market data, the author offers customizations according to a client's specific needs.
This report will be delivered within 3 business days and will include the latest impact analysis of COVID-19.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- AlloSource
- Anterogen Co., Ltd.
- MEDIPOST Co., Ltd.
- NuVasive, Inc.
- Osiris Therapeutics, Inc.
- Pharmicell Co., Ltd.
1. Product Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Stem Cell Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Allogeneic, Autologous, Syngeneic)
5.2.2. By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood Derived, iPSCs, Others)
5.2.3. By Application (Musculoskeletal, Wound & Injury, Cardiovascular Disease (CVD), Surgery, Acute Graft-Versus-Host Disease, Drug Discovery & Development, Others)
5.2.4. By End Users (Hospitals v/s Clinics)
5.2.5. By Company (2019)
5.2.6. By Region
5.3. Product Market Map
6. Asia-Pacific Stem Cell Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Source of Stem Cells
6.2.3. By Application
6.2.4. By End Users
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Stem Cell Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Source of Stem Cells
6.3.1.2.3. By Application
6.3.1.2.4. By End Users
6.3.2. India Stem Cell Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Source of Stem Cells
6.3.2.2.3. By Application
6.3.2.2.4. By End Users
6.3.3. Australia Stem Cell Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Source of Stem Cells
6.3.3.2.3. By Application
6.3.3.2.4. By End Users
6.3.4. Japan Stem Cell Therapy Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Source of Stem Cells
6.3.4.2.3. By Application
6.3.4.2.4. By End Users
6.3.5. South Korea Stem Cell Therapy Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Source of Stem Cells
6.3.5.2.3. By Application
6.3.5.2.4. By End Users
7. Europe Stem Cell Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Source of Stem Cells
7.2.3. By Application
7.2.4. By End Users
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Stem Cell Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Source of Stem Cells
7.3.1.2.3. By Application
7.3.1.2.4. By End Users
7.3.2. Germany Stem Cell Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Source of Stem Cells
7.3.2.2.3. By Application
7.3.2.2.4. By End Users
7.3.3. United Kingdom Stem Cell Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Source of Stem Cells
7.3.3.2.3. By Application
7.3.3.2.4. By End Users
7.3.4. Italy Stem Cell Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Source of Stem Cells
7.3.4.2.3. By Application
7.3.4.2.4. By End Users
7.3.5. Spain Stem Cell Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Source of Stem Cells
7.3.5.2.3. By Application
7.3.5.2.4. By End Users
8. North America Stem Cell Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Source of Stem Cells
8.2.3. By Application
8.2.4. By End Users
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Stem Cell Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Source of Stem Cells
8.3.1.2.3. By Application
8.3.1.2.4. By End Users
8.3.2. Mexico Stem Cell Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Source of Stem Cells
8.3.2.2.3. By Application
8.3.2.2.4. By End Users
8.3.3. Canada Stem Cell Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Source of Stem Cells
8.3.3.2.3. By Application
8.3.3.2.4. By End Users
9. South America Stem Cell Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Source of Stem Cells
9.2.3. By Application
9.2.4. By End Users
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Stem Cell Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Source of Stem Cells
9.3.1.2.3. By Application
9.3.1.2.4. By End Users
9.3.2. Argentina Stem Cell Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Source of Stem Cells
9.3.2.2.3. By Application
9.3.2.2.4. By End Users
9.3.3. Colombia Stem Cell Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Source of Stem Cells
9.3.3.2.3. By Application
9.3.3.2.4. By End Users
10. Middle East and Africa Stem Cell Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Source of Stem Cells
10.2.3. By Application
10.2.4. By End Users
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Stem Cell Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Source of Stem Cells
10.3.1.2.3. By Application
10.3.1.2.4. By End Users
10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Source of Stem Cells
10.3.2.2.3. By Application
10.3.2.2.4. By End Users
10.3.3. UAE Stem Cell Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Source of Stem Cells
10.3.3.2.3. By Application
10.3.3.2.4. By End Users
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Osiris Therapeutics, Inc.
13.2. MEDIPOST Co., Ltd.
13.3. Anterogen Co., Ltd.
13.4. Pharmicell Co., Ltd.
13.5. Holostem Terapie Avanzate S.r.l.
13.6. JCR Pharmaceuticals Co., Ltd.
13.7. NuVasive, Inc.
13.8. RTI Surgical, Inc.
13.9. AlloSource
13.10. Thermo Fisher Scientific
14. Strategic Recommendations
15. About Us & Disclaimer
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Global Stem Cell Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Allogeneic, Autologous, Syngeneic)
5.2.2. By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood Derived, iPSCs, Others)
5.2.3. By Application (Musculoskeletal, Wound & Injury, Cardiovascular Disease (CVD), Surgery, Acute Graft-Versus-Host Disease, Drug Discovery & Development, Others)
5.2.4. By End Users (Hospitals v/s Clinics)
5.2.5. By Company (2019)
5.2.6. By Region
5.3. Product Market Map
6. Asia-Pacific Stem Cell Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Source of Stem Cells
6.2.3. By Application
6.2.4. By End Users
6.2.5. By Country
6.3. Asia-Pacific: Country Analysis
6.3.1. China Stem Cell Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Source of Stem Cells
6.3.1.2.3. By Application
6.3.1.2.4. By End Users
6.3.2. India Stem Cell Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Source of Stem Cells
6.3.2.2.3. By Application
6.3.2.2.4. By End Users
6.3.3. Australia Stem Cell Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Source of Stem Cells
6.3.3.2.3. By Application
6.3.3.2.4. By End Users
6.3.4. Japan Stem Cell Therapy Market Outlook
6.3.4.1. Market Size & Forecast
6.3.4.1.1. By Value
6.3.4.2. Market Share & Forecast
6.3.4.2.1. By Type
6.3.4.2.2. By Source of Stem Cells
6.3.4.2.3. By Application
6.3.4.2.4. By End Users
6.3.5. South Korea Stem Cell Therapy Market Outlook
6.3.5.1. Market Size & Forecast
6.3.5.1.1. By Value
6.3.5.2. Market Share & Forecast
6.3.5.2.1. By Type
6.3.5.2.2. By Source of Stem Cells
6.3.5.2.3. By Application
6.3.5.2.4. By End Users
7. Europe Stem Cell Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Source of Stem Cells
7.2.3. By Application
7.2.4. By End Users
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. France Stem Cell Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Source of Stem Cells
7.3.1.2.3. By Application
7.3.1.2.4. By End Users
7.3.2. Germany Stem Cell Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Source of Stem Cells
7.3.2.2.3. By Application
7.3.2.2.4. By End Users
7.3.3. United Kingdom Stem Cell Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Source of Stem Cells
7.3.3.2.3. By Application
7.3.3.2.4. By End Users
7.3.4. Italy Stem Cell Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Source of Stem Cells
7.3.4.2.3. By Application
7.3.4.2.4. By End Users
7.3.5. Spain Stem Cell Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Source of Stem Cells
7.3.5.2.3. By Application
7.3.5.2.4. By End Users
8. North America Stem Cell Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Source of Stem Cells
8.2.3. By Application
8.2.4. By End Users
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Stem Cell Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Source of Stem Cells
8.3.1.2.3. By Application
8.3.1.2.4. By End Users
8.3.2. Mexico Stem Cell Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Source of Stem Cells
8.3.2.2.3. By Application
8.3.2.2.4. By End Users
8.3.3. Canada Stem Cell Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Source of Stem Cells
8.3.3.2.3. By Application
8.3.3.2.4. By End Users
9. South America Stem Cell Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Source of Stem Cells
9.2.3. By Application
9.2.4. By End Users
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Stem Cell Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Source of Stem Cells
9.3.1.2.3. By Application
9.3.1.2.4. By End Users
9.3.2. Argentina Stem Cell Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Source of Stem Cells
9.3.2.2.3. By Application
9.3.2.2.4. By End Users
9.3.3. Colombia Stem Cell Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Source of Stem Cells
9.3.3.2.3. By Application
9.3.3.2.4. By End Users
10. Middle East and Africa Stem Cell Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Source of Stem Cells
10.2.3. By Application
10.2.4. By End Users
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Stem Cell Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Source of Stem Cells
10.3.1.2.3. By Application
10.3.1.2.4. By End Users
10.3.2. Saudi Arabia Stem Cell Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Source of Stem Cells
10.3.2.2.3. By Application
10.3.2.2.4. By End Users
10.3.3. UAE Stem Cell Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Source of Stem Cells
10.3.3.2.3. By Application
10.3.3.2.4. By End Users
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1. Osiris Therapeutics, Inc.
13.2. MEDIPOST Co., Ltd.
13.3. Anterogen Co., Ltd.
13.4. Pharmicell Co., Ltd.
13.5. Holostem Terapie Avanzate S.r.l.
13.6. JCR Pharmaceuticals Co., Ltd.
13.7. NuVasive, Inc.
13.8. RTI Surgical, Inc.
13.9. AlloSource
13.10. Thermo Fisher Scientific
14. Strategic Recommendations
15. About Us & Disclaimer
Note: Product cover images may vary from those shown
- Osiris Therapeutics, Inc.
- MEDIPOST Co., Ltd.
- Anterogen Co., Ltd.
- Pharmicell Co., Ltd.
- Holostem Terapie Avanzate S.r.l.
- JCR Pharmaceuticals Co., Ltd.
- NuVasive, Inc.
- RTI Surgical, Inc.
- AlloSource
- Thermo Fisher Scientific
Note: Product cover images may vary from those shown
